← Browse by Condition
Medical Condition
neoplasms by site
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2, Phase 3, Phase 1, Phase 2
NCT04493632
Recruiting
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
Enrollment
500 pts
Location
Spain, United Kingdo...
Sponsor
OncoSil Medical Limited
NCT05770544 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT04949282
Recruiting
Spanish Series of Patients Treated With the Radionuclide Lutetium177
Enrollment
5,000 pts
Location
Spain
Sponsor
Sociedad Española de Medicina ...
NCT04572451 Phase 1
Recruiting
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma
Enrollment
50 pts
Location
United States
Sponsor
Yana Najjar
NCT06988475 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT03911388 Phase 1
Recruiting
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Enrollment
24 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05252078 Phase 2
Recruiting
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
Enrollment
30 pts
Location
China
Sponsor
Jiangxi Provincial Cancer Hosp...
NCT05592626 Phase 1, Phase 2
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Enrollment
365 pts
Location
United States, Canad...
Sponsor
Marengo Therapeutics, Inc.